Related Experiment Video
Updated: Jan 5, 2026

08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
5.7K
How to develop therapeutic and translational research collaborations with industry.
Robin J Kleiman1, Michael D Ehlers1
1Research and Development, Biogen, Cambridge, MA 02142.
Molecular Biology of the Cell
|October 15, 2019
Summary
Academic and industry scientists collaborate to discover new medicines. Understanding each partner's strengths and scope is key for successful therapeutic and translational research collaborations.
Area of Science:
- Drug discovery and development
- Translational research
- Academic-industry partnerships
Background:
- New medicine discovery relies on academic and industrial scientists.
- Effective collaboration requires mutual understanding of partner capabilities.
- Bridging academic and industry research is crucial for therapeutic advancements.
Purpose of the Study:
- To outline key considerations for academic-industry research collaborations.
- To define the optimal framework for therapeutic and translational research partnerships.
- To provide a perspective on establishing successful collaborations.
Main Methods:
- Perspective-based analysis of collaboration factors.
- Identification of essential elements for partnership success.
- Framework development for academic-industry engagement.
Main Results:
- Mutual understanding of specialized capabilities is essential.
- Clear definition of scope of work for each partner is critical.
- A structured approach to collaboration enhances success.
Conclusions:
- Successful drug discovery necessitates strong academic-industry alliances.
- Appreciating distinct partner contributions optimizes research outcomes.
- Establishing clear communication and defined roles facilitates therapeutic and translational research.
Related Concept Videos
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Microorganisms in Medicine and Therapeutics
905
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
905
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K

